Leading the Fight to treat and cure Tay-Sachs, Canavan, Sandhoff, GM1 and related diseases
Donate
Modified on 14 December 2018 228 downloads
2018 Dec 13 Press Release Axovant Licenses GM2 and GM1 Gene Therapies.pdf
Modified on 21 September 2015 3013 downloads
NTSAD_2015 Research Grants final corrected.pdf
National Tay-Sachs & Allied Diseases Announces Research Initiative Grant Recipients
Nation’s first patient advocacy organization awards five grants totaling $266,000
September 18, 2015—BOSTON, MA—National Tay-Sachs & Allied Diseases Association (NTSAD), the nation’s first patient advocacy organization, today announced the awardees of its 2015 Innovative Research Grants. Reflecting an ongoing commitment to fund research aligned with its mission to lead the fight to treat and cure Tay-Sachs (TSD), GM-1, Sandhoff, Canavan (CD) and other related genetic diseases, NTSAD has solicited proposals for basic, translational or clinical research projects. This year’s grants include projects related to newborn screening, gene therapy delivery methods, animal models and international patient registries.
Read more by selecting the .pdf
1086 downloads
NTSAD-CAC-Press-Release.pdf
Username
Password
Remember Me